Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HNC9
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 12 |
GO:0006793 | phosphorus metabolic process | 3 | 12 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016310 | phosphorylation | 5 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004672 | protein kinase activity | 3 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0005524 | ATP binding | 5 | 12 |
GO:0016301 | kinase activity | 4 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 12 |
GO:0017076 | purine nucleotide binding | 4 | 12 |
GO:0030554 | adenyl nucleotide binding | 5 | 12 |
GO:0032553 | ribonucleotide binding | 3 | 12 |
GO:0032555 | purine ribonucleotide binding | 4 | 12 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 12 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 12 |
GO:0036094 | small molecule binding | 2 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043168 | anion binding | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0097367 | carbohydrate derivative binding | 2 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
GO:1901265 | nucleoside phosphate binding | 3 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 2 |
GO:0106310 | protein serine kinase activity | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 277 | 281 | PF00656 | 0.589 |
CLV_NRD_NRD_1 | 136 | 138 | PF00675 | 0.309 |
CLV_NRD_NRD_1 | 21 | 23 | PF00675 | 0.654 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.309 |
CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.589 |
CLV_PCSK_SKI1_1 | 235 | 239 | PF00082 | 0.388 |
CLV_Separin_Metazoa | 167 | 171 | PF03568 | 0.336 |
DEG_APCC_DBOX_1 | 191 | 199 | PF00400 | 0.165 |
DEG_APCC_DBOX_1 | 234 | 242 | PF00400 | 0.388 |
DEG_SPOP_SBC_1 | 2 | 6 | PF00917 | 0.594 |
DOC_ANK_TNKS_1 | 111 | 118 | PF00023 | 0.165 |
DOC_CYCLIN_RxL_1 | 229 | 240 | PF00134 | 0.427 |
DOC_CYCLIN_yCln2_LP_2 | 191 | 197 | PF00134 | 0.286 |
DOC_MAPK_JIP1_4 | 235 | 241 | PF00069 | 0.307 |
DOC_PP4_FxxP_1 | 223 | 226 | PF00568 | 0.388 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.653 |
DOC_WW_Pin1_4 | 207 | 212 | PF00397 | 0.270 |
DOC_WW_Pin1_4 | 214 | 219 | PF00397 | 0.227 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.427 |
LIG_14-3-3_CanoR_1 | 137 | 147 | PF00244 | 0.410 |
LIG_14-3-3_CanoR_1 | 22 | 30 | PF00244 | 0.634 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.453 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.522 |
LIG_FHA_1 | 198 | 204 | PF00498 | 0.277 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.559 |
LIG_FHA_2 | 139 | 145 | PF00498 | 0.285 |
LIG_Integrin_RGD_1 | 170 | 172 | PF01839 | 0.307 |
LIG_LIR_Apic_2 | 222 | 226 | PF02991 | 0.391 |
LIG_LIR_Gen_1 | 64 | 75 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 64 | 70 | PF02991 | 0.478 |
LIG_NRBOX | 182 | 188 | PF00104 | 0.336 |
LIG_PAM2_1 | 214 | 226 | PF00658 | 0.271 |
LIG_SH2_STAT5 | 174 | 177 | PF00017 | 0.423 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.390 |
LIG_SH3_3 | 191 | 197 | PF00018 | 0.316 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.453 |
LIG_SUMO_SIM_par_1 | 235 | 240 | PF11976 | 0.242 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.670 |
MOD_CK1_1 | 214 | 220 | PF00069 | 0.249 |
MOD_CK1_1 | 263 | 269 | PF00069 | 0.650 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.695 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.285 |
MOD_CK2_1 | 264 | 270 | PF00069 | 0.617 |
MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.209 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.343 |
MOD_GlcNHglycan | 229 | 232 | PF01048 | 0.325 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.307 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.279 |
MOD_GSK3_1 | 260 | 267 | PF00069 | 0.709 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.694 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.602 |
MOD_NEK2_1 | 274 | 279 | PF00069 | 0.462 |
MOD_PIKK_1 | 56 | 62 | PF00454 | 0.526 |
MOD_PKA_2 | 23 | 29 | PF00069 | 0.600 |
MOD_Plk_2-3 | 260 | 266 | PF00069 | 0.605 |
MOD_Plk_4 | 219 | 225 | PF00069 | 0.271 |
MOD_Plk_4 | 245 | 251 | PF00069 | 0.307 |
MOD_ProDKin_1 | 207 | 213 | PF00069 | 0.270 |
MOD_ProDKin_1 | 214 | 220 | PF00069 | 0.227 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.432 |
TRG_DiLeu_BaEn_1 | 204 | 209 | PF01217 | 0.295 |
TRG_DiLeu_BaLyEn_6 | 233 | 238 | PF01217 | 0.357 |
TRG_ENDOCYTIC_2 | 67 | 70 | PF00928 | 0.471 |
TRG_ER_diArg_1 | 136 | 138 | PF00400 | 0.316 |
TRG_ER_diArg_1 | 21 | 24 | PF00400 | 0.582 |
TRG_ER_diArg_1 | 43 | 46 | PF00400 | 0.405 |
TRG_NES_CRM1_1 | 240 | 256 | PF08389 | 0.334 |
TRG_Pf-PMV_PEXEL_1 | 235 | 240 | PF00026 | 0.441 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IAR1 | Leptomonas seymouri | 59% | 95% |
A0A1X0P5S2 | Trypanosomatidae | 33% | 100% |
A0A3Q8IFJ8 | Leishmania donovani | 77% | 98% |
A0A3R7MHW5 | Trypanosoma rangeli | 30% | 71% |
A0A422P1C1 | Trypanosoma rangeli | 32% | 100% |
C9ZL78 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 67% |
C9ZYK5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 100% |
E9AFT9 | Leishmania major | 79% | 100% |
E9AHW8 | Leishmania infantum | 77% | 98% |
E9B6Z1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 98% |
O00506 | Homo sapiens | 24% | 66% |
O70150 | Rattus norvegicus | 28% | 82% |
Q14012 | Homo sapiens | 26% | 76% |
Q3SWY6 | Bos taurus | 24% | 66% |
Q63450 | Rattus norvegicus | 26% | 75% |
Q6P2M8 | Homo sapiens | 28% | 82% |
Q8BW96 | Mus musculus | 24% | 73% |
Q8IU85 | Homo sapiens | 24% | 73% |
Q91YS8 | Mus musculus | 26% | 75% |
Q9QYK9 | Mus musculus | 28% | 82% |
Q9Z2W1 | Mus musculus | 24% | 66% |
W0LYS5 | Macrobrachium nipponense | 23% | 82% |